Belgian drugmaker Galapagos announced Monday the planned retirement of co-founder and CEO Onno van de Stolpe, marking an end to a more than two-decade stretch with him at the helm.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,